Alzheimer’s Drug Leqembi Gets Full FDA and MEDICARE Approval
July 7, 2023
No Comments
First drug to modestly slow Alzheimer’s cognitive decline, based on 1,800 patients.
Drugs
FDA Unanimously Votes Leqembi Benefits Alzheimer’s
June 11, 2023
1 Comment
The FDA Advisory Committee’s endorsement of Leqembi paves way for traditional approval, ushers in a new era for Alzheimer’s
FDA Votes 9-1 to Advance Rexulti for Alzheimer’s
May 15, 2023
No Comments
The FDA has approved the supplemental New Drug Application (sNDA) of REXULTI® (brexpiprazole) for the treatment of agitation associated with Alzheimer’s. It’s the first such treatment to be approved in the US. Learn more.
Next Alzheimer’s Drug? Donamebab Significantly Slows Cognitive Decline
May 3, 2023
No Comments
Eli Lilly Company’s TRAILBLAZER-ALZ 2 Phase 3 study shows that donanemab significantly slowed cognitive and functional decline in people with early symptomatic Alzheimer’s disease. Learn more.
FDA Okays Trial of Alzheimer’s Pill with Unique Mechanism
January 25, 2023
No Comments
The new Alzheimer’s injections Aduhelm and Lecanemab offer hope. Now, Mastinimab is trying to break through to the next level with a simpler pill. Mastinimab fights Alzheimer’s via a revolutionary mechanism of action. Learn why the FDA approved Mastinimab’s final round of trials.
Lecanemab Enters Advanced Alzheimer’s Gene Trials
February 13, 2022
No Comments
VIDEO + ARTICLE: Phase II/III trials are begining in the Tau NextGen study. The study will assess the effect of Lecanemab, an experimental anti-amyloid therapy,
The ABC’s of Alzheimer’s, Bladders and Cholinesterase Inhibitors
January 14, 2022
No Comments
Researchers in Houston, Texas find that taking a cholinesterase inhibitor such as donepezil may increase one’s trips to the bathroom. Learn more.
FDA-Approved Bumetanide Could Be Next Alzheimer’s Drug
November 8, 2021
No Comments
OLD-NEW DRUG RESEARCH: The diuretic bumetanide, used for more than 30 years to treat hypertension and heart failure, was also found to reverse signs of
Experimental Drug Buntanetap Completes Phase 2 Trials
January 17, 2020
No Comments
VIDEO + ARTICLE: An experimental drug produced by Annovis has received its generic name following successful completion of its Phase II trials. Buntanetap is intended
You Might Also Like
Recent Stories
3 Battery-Operated Dementia Clocks
April 7, 2025
If your loved one asks a little too often, “What’s the time?” “What day is it?”, easily solve the problem with these Battery-Operated Dementia-Calendar-Clocks. No wires, hang them on any wall, stand them on any table.
PCA Affects Vision Before Memory in Alzheimer’s
April 6, 2025
Why can vision loss come before memory loss in 10% of Alzheimer’s? A new study shows Posterior Cortical Atrophy (PCA), a type of Alzheimer’s, distributes proteins differently.
What Starts Alzheimer’s, What Stops It?
April 4, 2025
VIDEO: Vascular neglect triggers Alzheimer’s decades before symptoms appear. See how to use that knowledge to lower risk and slow its advance.
On Trend
Most Popular Stories
85 with Dementia? Good Chance It’s HS-AGING, Not Alzheimer’s
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
A Grandchild for One Day Keeps Dementia Away
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
“I’ve Got You Under My Skin,” By Dad with Dementia & Son
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
Is Alzheimer’s Catchy?
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
Get The Latest Updates
Subscribe To Our Weekly Newsletter
No spam, only news and updates.
Books
Social Media
Categories
New Posts
20% Less Dementia with Shingles Vaccine
April 18, 2025
Biogen Targets Alzheimer’s Tau
April 17, 2025
Thought of the Week: Twice the Presence
April 17, 2025